Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Financial Disclosure
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
Legal & Privacy Compliance
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
Cardlytics, Inc. is a U.S. business entity operating within the Services-Computer Programming, Data Processing, Etc. sector (SIC 7370). Publicly traded on the Nasdaq under the ticker symbol CDLX, the company is incorporated in Delaware. Based on SEC EDGAR filings, CDLX reported fiscal year 2025 revenue of $212.3M, reflecting a year-over-year decline of 16.9%. Our proprietary Semantic Risk Score of 14 indicates high transparency and low reporting risk, derived from the frequency and consistency of 10-K, 10-Q, and 8-K filing patterns. As part of the SIC 7370 classification, Cardlytics, Inc. serves as a key benchmark for investors and analysts monitoring Delaware corporate performance.
Filing data sourced from SEC EDGAR signals. 10-K = annual report · 10-Q = quarterly · 8-K = material event.
Financial Performance
Revenue -16.9% YoY
Financial Insights
FY2025 · derived from SEC EDGAR XBRL filings
Cardlytics, Inc. — what the latest 10-K shows
Cardlytics, Inc. (CDLX) reported revenue of $212.3M for fiscal year 2025, down 16.9% from $255.6M in FY2024.
Across 4 fiscal years, CDLX revenue declined at a 4.8% annual rate (CAGR), expanding from $258.8M in FY2021 to $212.3M in FY2025.
Net loss reached $103.5M in FY2025, equivalent to a -48.7% net margin (negative) on revenue of $212.3M.
Year-over-year net income rose by 45.3% (FY2024: -$189.3M → FY2025: -$103.5M).
Operating income of -$101.8M in FY2025 translated into an operating margin of -48.0%, a key efficiency benchmark before interest and taxes.
Total assets shrank by 27.3% year over year, ending FY2025 at $285.6M on the consolidated balance sheet.
Debt-to-equity stood at -44.89 at the close of FY2025 (total liabilities $292.1M, stockholders' equity -$6.5M), pointing to a conservative capital structure.
Current ratio of 1.75 at FY2025 year-end (current assets $137.3M vs. current liabilities $78.4M) reflects adequate short-term coverage.
Cardlytics, Inc. operates in the Services-Computer Programming, Data Processing, Etc. sector and discloses these figures via SEC EDGAR XBRL filings, which are the audited numerical filings the SEC has required since 2009.
Numbers parsed from us-gaap XBRL tags in the company's most recent annual report.View source on SEC EDGAR →
Current RatioCurrent assets / current liabilities. Above 1.0 = solvent.
1.75
1.91
▼ Lagging
Source: SEC EDGAR XBRL filings (10-K annual reports). Industry benchmarks derived from 53 companies in SIC 7370.
Disclaimer: All financial data is sourced from raw SEC EDGAR filings. Sprytne.com provides automated data visualization and algorithmic analysis for informational purposes only. This is NOT financial advice, a recommendation to buy/sell, or a guarantee of accuracy. Always verify data via official SEC sources before making investment decisions.
🚢
Supply Chain Intelligence
Import activity for Cardlytics, Inc. — based on US Customs & Border Protection (CBP) manifests.
Yes. Cardlytics, Inc. (SEC CIK 0001666071, ticker CDLX) is registered with the U.S. Securities and Exchange Commission and files periodic reports such as 10-K (annual) and 10-Q (quarterly). All filings are publicly available via SEC EDGAR.
What industry is Cardlytics, Inc. in?+
Cardlytics, Inc. operates in the Services-Computer Programming, Data Processing, Etc. sector (SIC 7370, NAICS 541512). Sprytne tracks 97 peers in this sector.
How much revenue did Cardlytics, Inc. generate in 2025?+
Cardlytics, Inc. (CDLX) reported total revenue of $212.3M for fiscal year 2025, according to SEC EDGAR 10-K filings.
What is the profit margin of CDLX?+
Cardlytics, Inc. reported a net profit margin of -48.7% for fiscal year 2025. The industry average net margin for Services-Computer Programming, Data Processing, Etc. (SIC 7370) is -29.4%.
Affiliate link · sprytne.com may earn a commission
Methodology & compliance note
Data is aggregated from SEC EDGAR and Secretary of State public records. Any analytics such as "market share" are statistical estimates (proxy models) and are not official audits, valuations, or investment advice. Sprytne.com is an independent data aggregator and is not affiliated with any government agency.Learn more →
Data synchronized via offline indexes + SEC/SOS signals.
What is the operating margin of CDLX?+
Cardlytics, Inc. achieved an operating margin of -48%, compared to the sector average of -18.28%. This metric reflects the company's operational efficiency before interest and taxes.
Is Cardlytics, Inc. growing faster than its competitors?+
Cardlytics, Inc.'s revenue declined by 16.9% year-over-year (FY2024 to FY2025), from $255.6M to $212.3M. The company operates in the Services-Computer Programming, Data Processing, Etc. sector with 97 tracked peers.
What is the debt-to-equity ratio of CDLX?+
Cardlytics, Inc. has a debt-to-equity ratio of -44.89, indicating conservative leverage. The sector average is -4.63. This ratio is calculated from audited 10-K filings as total liabilities divided by stockholders' equity.
How did Cardlytics, Inc.'s revenue change from FY2024 to FY2025?+
Revenue declined 16.9% year over year, moving from $255.6M in FY2024 to $212.3M in FY2025, according to the company's CDLX 10-K filings on SEC EDGAR.
What was Cardlytics, Inc.'s net loss in fiscal year 2025?+
Cardlytics, Inc. reported a net loss of $103.5M in FY2025, translating to a -48.7% negative margin against $212.3M of revenue. Source: 10-K filing on SEC EDGAR.
What is Cardlytics, Inc.'s leverage profile?+
Cardlytics, Inc.'s most recent 10-K shows total liabilities of $292.1M against stockholders' equity of -$6.5M at FY2025 year-end — a debt-to-equity ratio of -44.89, indicating a conservative capital structure.
Cardlytics, Inc. — $212M Revenue (2025) · SEC Filings & Company Profile | Sprytne.com